For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Op-Eds
Noisy Spring: Avoiding the West Nile virus
The six-year-old U.S. outbreak of West Nile virus is a significant threat to public health and shows no signs of abating. Last year, there were…
Op-Eds
Pesticides Not a Threat to Students
The anti-pesticide crowd tried to scare parents last week with a new report alleging that pesticide use in schools is dangerous for students.
Citation
Small Tobacco Brands Hit by Payments
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY A new study raises concerns about the health effects on children of pesticides…
Newsletter
The Competitive Enterprise Institute Daily Update
1. BUDGET The highway bill currently before Congress is igniting the wrath of fiscal conservatives for being loaded with spending for questionable…
Bond Buyer